DOES EXIST DEPENDENCE OF DOSE VALUES IN ORGANS OF RISK (OAR) AND PROGNOSTIC FACTORS UNDER HDR BRACHYTHERAPY (HDR-BT) OF PROSTATE CANCER?

被引：0
|
作者：
Skowronek, J. [1 ]
Chichel, A. [1 ]
Kanikowski, M. [1 ]
Zwierzchowski, G. [2 ]
机构：
[1] Greatpoland Canc Ctr, Brachytherapy, Poznan, Poland
[2] Greatpoland Canc Ctr, Dept Med Phys, Poznan, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2009年 / 91卷
关键词：
D O I：
10.1016/S0167-8140(15)34399-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [31] Interstitial high dose rate (HDR) brachytherapy under local anesthesia for early stage prostate cancer
    White, D.
    Mark, R.
    Anderson, P.
    Nair, M.
    Neumann, T.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S449 - S449
  • [32] Single fraction HDR brachytherapy in low-risk prostate cancer: a search for the best dose level
    Luthart, L.
    Kolkman-Deurloo, I. K. K.
    Busser, W. M. H.
    Aluwini, S.
    Christianen, M. E. M. C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1251 - S1251
  • [33] Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients
    Martell, K.
    Mendez, L. C.
    Chung, H. T.
    Tseng, C. L.
    Alayed, Y.
    Cheung, P.
    Liu, S.
    Vesprini, D.
    Chu, W.
    Wronski, M.
    Szumacher, E.
    Ravi, A.
    Loblaw, A.
    Morton, G.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 149 - 155
  • [34] Dose-volume-time-impact on toxicity in interstitial temporary HDR-Ir-192-brachytherapy (BT) for prostate cancer
    Pinkawa, M
    Fischedick, K
    Treusacher, H
    Demirel, G
    Mager, R
    Borchers, H
    Jakse, G
    Eble, MJ
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S122 - S122
  • [35] EXPERIENCE OF IMAGE-GUIDED HDR BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER WITH FAVORABLE PROGNOSTIC FACTORS IN THE REPUBLIC OF BELARUS
    Slobina, E. L.
    Polyakov, S.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S282 - S283
  • [36] Stereotactic body radiotherapy (SBRT) versus high dose rate (HDR) brachytherapy (BT) boost for high-risk (HR) prostate cancer.
    Gonzalez-Motta, Alejandro
    Roach, Mack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [37] Interstitial high dose rate (HDR) brachytherapy under local anesthesia for early stage prostate cancer.
    Vallabhan, G
    Mark, R
    Akins, R
    Anderson, P
    Neumann, T
    Nair, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 433S - 433S
  • [38] Prospective Evaluation of Stereotactic Radiotherapy for Low and Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dose Distribution
    Fuller, D. B.
    Mardirossian, G.
    Wong, D.
    McKellar, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S358 - S359
  • [39] Differences of Dose to Pelvic Organs at Risk (OAR) with Use of Vaginal Multi-Channel Cylinder Applicator for Adjuvant High-Dose Rate (HDR) Brachytherapy to the Vaginal Cuff
    Neicu, T.
    Valakh, V.
    Chan, P.
    Charpentier, P.
    Li, S.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [40] Similar 5-year clinical outcome for high dose rate (HDR) and low dose rate (LDR) brachytherapy (BT) for early prostate cancer
    Ghilezan, M
    Vargas, C
    Gustafson, G
    Boike, T
    Chao, K
    Kestin, L
    Grills, I
    Sebastian, E
    Martinez, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S37 - S37
12345